Novel adamantane-chloroquinolin conjugates to overcome plasmodium falciparum chloroquine resistance

Simple item page
dc.contributor.advisorJoubert, Jacques
dc.contributor.advisorMalan, Sarel
dc.contributor.authorYvette, Mofenge Opute
dc.date.accessioned2018-04-11T10:00:03Z
dc.date.accessioned2024-10-29T13:17:59Z
dc.date.available2018-04-11T10:00:03Z
dc.date.available2024-10-29T13:17:59Z
dc.date.issued2017
dc.descriptionMagister Scientiae - MSc (Pharmaceutical Chemistry)
dc.description.abstractMalaria poses devastating health and socioeconomic outcomes on global health especially among pregnant women and children below the age of 5 in endemic areas. This is exacerbated by Plasmodium falciparum resistance to available antimalarial drugs, especially chloroquine (CQ), which was the drug of choice for many years against the blood stage of malaria.
dc.identifier.urihttps://hdl.handle.net/10566/16351
dc.language.isoen
dc.publisherUniversity of the Western Cape
dc.rights.holderUniversity of the Western Cape
dc.titleNovel adamantane-chloroquinolin conjugates to overcome plasmodium falciparum chloroquine resistance

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Yvette_MSc_NSC_2017.pdf
Size:
9 MB
Format:
Adobe Portable Document Format
Download

Collections

Magister Scientiae - MSc (Pharmaceutical Chemistry)